ORMP
ORMP
US68403P2039
Oramed Pharmaceuticals Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
177.21M EUR
198.72M EUR
139.15M EUR
111.93M EUR
Enterprise Value
124.83M EUR
184.21M EUR
126.71M EUR
66.81M EUR
Valuation Multiples
Trailing P/E
1.05x
1.14x
1.26x
1.56x
Forward P/E
-54.13x
--
--
--
Price to Sales
--
--
--
--
Price to Book
0.56x
0.63x
0.58x
0.56x
EV/Revenue
--
--
--
--
EV/EBITDA
-8.67x
10.08x
6.83x
1x
Price to FCF (P/FCF)
70.56x
--
--
--
EV/FCF
49.7x
--
--
--
FCF Yield
1.42%
-3.59%
-7.53%
-6.75%
ende